Antiviral Agents Against Respiratory Viruses
Open Access
- 12 August 2016
- book chapter
- book charpter
- Published by Elsevier BV
- p. 1318-1326.e2
- https://doi.org/10.1016/b978-0-7020-6285-8.00154-4
Abstract
No abstract availableThis publication has 85 references indexed in Scilit:
- Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trialBMJ, 2013
- Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: a randomized double blind placebo controlled trialJournal of Infection and Chemotherapy, 2013
- Phase III Randomized, Double-Blind Study Comparing Single-Dose Intravenous Peramivir with Oral Oseltamivir in Patients with Seasonal Influenza Virus InfectionAntimicrobial Agents and Chemotherapy, 2011
- Pharmacokinetics of oseltamivir according to trimester of pregnancyAmerican Journal of Obstetrics and Gynecology, 2011
- Pharmacokinetics of oseltamivir among pregnant and nonpregnant womenAmerican Journal of Obstetrics and Gynecology, 2011
- Pharmacokinetics of oseltamivir in breast milk and maternal plasmaAmerican Journal of Obstetrics and Gynecology, 2011
- Efficacy and Safety of Intravenous Peramivir for Treatment of Seasonal Influenza Virus InfectionAntimicrobial Agents and Chemotherapy, 2010
- Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort studyThe Lancet Infectious Diseases, 2010
- Oseltamivir Dosing for Influenza Infection in Premature NeonatesThe Journal of Infectious Diseases, 2010
- Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate (CS-8958) versus Oseltamivir as Treatment for Children with Influenza Virus InfectionAntimicrobial Agents and Chemotherapy, 2010